Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aphios has received a Japanese patent for its phospholipid nanosomes technology platform for the encapsulation of hydrophobic drugs.
Subscribe to our email newsletter
Phospholipid nanosomes are nanometer-sized vesicles of phospholipid bilayers comprised of single or multiple lipid bilayers. As such, they are said to be non-toxic, non-antigenic and biodegradable in character since they have the molecular characteristics of mammalian cell membranes.
Trevor Castor, CEO of Aphios, said: “This technology does not utilize organic solvents that could be harmful to the therapeutic, the recipient or the environment and is rapid, broadly-applicable and scalable while enhancing drug delivery.”